Literature DB >> 24014425

Hypereosinophilic syndrome associated with ulcerative colitis presenting with recurrent Loeffler's endocarditis and left ventricular thrombus treated successfully with immune suppressive therapy and anticoagulation.

Srikanth Koneru1, George Koshy, Colin Sharp, Alhossain A Khalafallah.   

Abstract

We reported a case of a 28-year-old Caucasian woman with hypereosinophilic syndrome (HES) associated with ulcerative colitis who presented on separate occasions with Loeffler's endocarditis. She was admitted in 2008 with fever, headache, confusion and visual loss. Diagnostic workup uncovered an eosinophilia of 3.1×10⁹/L and major ECG abnormalities. Subsequent echocardiography revealed left ventricular wall motion abnormalities with mural thrombus. MRI brain scan showed multiple white matter lesions consistent with acute infarcts. She recovered rapidly with corticosteroids and anticoagulation. Four years later she re-presented with headache, fatigue and an eosinophilia of 13.4×10⁹/L. This occurred 3 months after cessation of immunosuppression and within 12 months of total colectomy for fulminant ulcerative colitis. Echocardiography was suggestive of hypereosinophilic endomyocardial fibrosis with left ventricular thrombus. Anticoagulation and corticosteroids were resumed with good effect. This report highlights the findings, treatment and outcome of ulcerative colitis-associated HES manifesting as recurrent Loeffler's endocarditis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24014425      PMCID: PMC3794253          DOI: 10.1136/bcr-2013-200919

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes.

Authors:  Vincenzo Pitini; Carmela Arrigo; Domenico Azzarello; Gaetana La Gattuta; Cinzia Amata; Maria Righi; Sebastiano Coglitore
Journal:  Blood       Date:  2003-11-01       Impact factor: 22.113

Review 2.  Troponin in hematologic oncology.

Authors:  Morie A Gertz
Journal:  Leuk Lymphoma       Date:  2008-02

3.  Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease.

Authors:  C Y Chew; G M Ziady; M J Raphael; M Nellen; C M Oakley
Journal:  Br Heart J       Date:  1977-04

4.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.

Authors:  Amy D Klion; Pierre Noel; Cem Akin; Melissa A Law; D Gary Gilliland; Jan Cools; Dean D Metcalfe; Thomas B Nutman
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

Review 5.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

Review 6.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

Review 7.  Neurologic manifestations of ulcerative colitis.

Authors:  R Scheid; N Teich
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

8.  Molecular characterization of paediatric idiopathic hypereosinophilia.

Authors:  Maria Cristina Rapanotti; Roberta Caruso; Emanuele Ammatuna; Serena Zaza; Laura Trotta; Mariadomenica Divona; Laura Cicconi; Daria Funaro; Giorgio Federici; Sergio Amadori; Giulio De Rossi; Francesco Lo-Coco
Journal:  Br J Haematol       Date:  2010-10-19       Impact factor: 6.998

Review 9.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

10.  Time course of eosinophilic myocarditis visualized by CMR.

Authors:  Kurt Debl; Behrus Djavidani; Stefan Buchner; Florian Poschenrieder; Norbert Heinicke; Stefan Feuerbach; Günter Riegger; Andreas Luchner
Journal:  J Cardiovasc Magn Reson       Date:  2008-05-08       Impact factor: 5.364

  10 in total
  5 in total

1.  Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps.

Authors:  Charlotte Marx; Julia Novotny; Danby Salbeck; Katie R Zellner; Leo Nicolai; Kami Pekayvaz; Badr Kilani; Sven Stockhausen; Niklas Bürgener; Danny Kupka; Thomas J Stocker; Ludwig T Weckbach; Joachim Pircher; Markus Moser; Michael Joner; Walter Desmet; Tom Adriaenssens; Franz-Josef Neumann; Anthony H Gerschlick; Jurrien M Ten Berg; Michael Lorenz; Konstantin Stark
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113

2.  Eosinophilia and Ulcerative Colitis Associated with Eosinophilic Myocarditis.

Authors:  Katie Murphy; Oral Waldo; Graham M Lohrmann; Henry D Tazelaar; Clinton E Jokerst; Farouk Mookadam
Journal:  Tex Heart Inst J       Date:  2017-06-01

Review 3.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

4.  Hypereosinophilia and Löffler's Endocarditis: A Systematic Review.

Authors:  Pramod Theetha Kariyanna; Naseem A Hossain; Neema Jayachamarajapura Onkaramurthy; Apoorva Jayarangaiah; Nimrah A Hossain; Amog Jayarangaiah; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2021-02-03

5.  Loeffler endocarditis with intracardiac thrombus: case report and literature review.

Authors:  Qian Zhang; Daoyuan Si; Zhongfan Zhang; Wenqi Zhang
Journal:  BMC Cardiovasc Disord       Date:  2021-12-28       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.